These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 2527263)

  • 21. Pumping ability of the hypertrophying left ventricle of the spontaneously hypertensive rat.
    Pfeffer MA; Pfeffer JM; Frohlich ED
    Circ Res; 1976 May; 38(5):423-9. PubMed ID: 131652
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Absence of hypertension despite chronic marked elevations in plasma norepinephrine in conscious dogs.
    King BD; Sack D; Kichuk MR; Hintze TH
    Hypertension; 1987 Jun; 9(6):582-90. PubMed ID: 2953682
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of cardiac hypertrophy on arterial and cardiopulmonary baroreflex control of renal sympathetic nerve activity in anaesthetized rats.
    Flanagan ET; Buckley MM; Aherne CM; Lainis F; Sattar M; Johns EJ
    Exp Physiol; 2008 Sep; 93(9):1058-64. PubMed ID: 18487313
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of cardiac angiotensin II in isoproterenol-induced left ventricular hypertrophy.
    Nagano M; Higaki J; Nakamura F; Higashimori K; Nagano N; Mikami H; Ogihara T
    Hypertension; 1992 Jun; 19(6 Pt 2):708-12. PubMed ID: 1534315
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Norepinephrine-induced cardiac hypertrophy of the cat heart.
    Marino TA; Cassidy M; Marino DR; Carson NL; Houser S
    Anat Rec; 1991 Apr; 229(4):505-10. PubMed ID: 1828654
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiac design and pressure-volume characteristics of the left ventricle in normotensive (WKY) and hypertensive (SHR) rats after various dietary sodium treatments.
    Friberg P; Ely DL; Wåhlander H; Nilsson H; Folkow B
    Acta Physiol Scand; 1986 Apr; 126(4):477-84. PubMed ID: 2940810
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Positive inotropic effect of exogenous and endogenous NO in hypertrophic rat hearts.
    Kojda G; Kottenberg K; Stasch JP; Schrör K; Noack E
    Br J Pharmacol; 1997 Nov; 122(5):813-20. PubMed ID: 9384495
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Time-course of changes in cardiac hypertrophy and pressor mechanisms in two-kidney, one clip hypertensive rats during treatment with minoxidil, enalapril or after uninephrectomy.
    Leenen FH; Prowse S
    J Hypertens; 1987 Feb; 5(1):73-83. PubMed ID: 2884253
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Basal and maximal inotropic state in renal hypertensive dogs with cardiac hypertrophy.
    Broughton A; Korner PI
    Am J Physiol; 1983 Jul; 245(1):H33-41. PubMed ID: 6223533
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential suppression of pressure-overload cardiac and aortic hypertrophy in rats by angiotensin-converting enzyme inhibitors.
    Wang DQ; Kakizoe E; Kobayashi Y; Shimoura K; Okunishi H
    Jpn J Pharmacol; 1999 Aug; 80(4):333-42. PubMed ID: 10496334
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structural and functional adaptation in the rat myocardium and coronary vascular bed caused by changes in pressure and volume load.
    Friberg P
    Acta Physiol Scand Suppl; 1985; 540():1-47. PubMed ID: 3161269
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Left ventricular pump function in renal hypertensive dogs with cardiac hypertrophy.
    Broughton A; Korner PI
    Am J Physiol; 1986 Dec; 251(6 Pt 2):H1260-6. PubMed ID: 2947477
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dietary sodium intake and left ventricular hypertrophy in normotensive rats.
    Yuan BX; Leenen FH
    Am J Physiol; 1991 Nov; 261(5 Pt 2):H1397-401. PubMed ID: 1835307
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rat strain-related differences in myocardial adrenergic tone and the impact on cardiac fibrosis, adrenergic responsiveness and myocardial structure and function.
    Osadchii O; Norton G; Deftereos D; Woodiwiss A
    Pharmacol Res; 2007 Apr; 55(4):287-94. PubMed ID: 17257851
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diastolic characteristics and cardiac energetics of isolated hearts exposed to volume and pressure overload.
    Friberg P
    Cardiovasc Res; 1988 May; 22(5):329-39. PubMed ID: 2973372
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlation of alpha-skeletal actin expression, ventricular fibrosis and heart function with the degree of pressure overload cardiac hypertrophy in rats.
    Stilli D; Bocchi L; Berni R; Zaniboni M; Cacciani F; Chaponnier C; Musso E; Gabbiani G; Clément S
    Exp Physiol; 2006 May; 91(3):571-80. PubMed ID: 16452123
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cocaine increases beta-myosin heavy-chain protein expression in cardiac myocytes.
    Henning RJ; Silva J; Reddy V; Kamat S; Morgan MB; Li YX; Chiou S
    J Cardiovasc Pharmacol Ther; 2000 Oct; 5(4):313-22. PubMed ID: 11150401
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Eprosartan reduces cardiac hypertrophy, protects heart and kidney, and prevents early mortality in severely hypertensive stroke-prone rats.
    Barone FC; Coatney RW; Chandra S; Sarkar SK; Nelson AH; Contino LC; Brooks DP; Campbell WG; Ohlstein EH; Willette RN
    Cardiovasc Res; 2001 Jun; 50(3):525-37. PubMed ID: 11376628
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of enalapril versus losartan on regression of volume overload-induced cardiac hypertrophy in rats.
    Ruzicka M; Yuan B; Leenen FH
    Circulation; 1994 Jul; 90(1):484-91. PubMed ID: 8026035
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Carbon monoxide-induced cardiac hypertrophy is not reduced by alpha- or beta-blockade in the rat.
    Penney DG; Formolo JM
    Toxicology; 1993 Jun; 80(2-3):173-87. PubMed ID: 8392228
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.